180 Life Sciences Corp.
ATNF
$1.19
$0.000.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
6/3/2023
-
Ticker Report
5/20/2023
-
GuruFocus
5/20/2023
-
Ticker Report
5/20/2023
-
Zolmax
5/19/2023
-
GuruFocus
5/12/2023
-
Ticker Report
4/27/2023
-
Ticker Report
4/17/2023
-
Ticker Report
4/10/2023
-
Globe Newswire
4/5/2023
-
Globe Newswire
4/5/2023
-
InvestorPlace
3/16/2023
-
Zolmax
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 15, 2023
Period Date
Friday, March 31, 2023
Next Filing
Week of Aug 7 and 11 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 507 0669
Address
Building 4
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Country
Year Founded
--
Business Description
Sector
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory...
more
